Jonathan Goodman, MPhil

Jonathan was the editor of Cancer Therapy Advisor from 2016 to 2018. His work has appeared in Aeon Magazine, The Week, and The Guardian, among other publications.

All articles by Jonathan Goodman, MPhil

Patient undergoing cardiovascular check-up.

Prostate Cancer

Risk of MACE Similar With Degarelix and Leuprolide in Prostate Cancer

Jonathan Goodman, MPhil

November 17, 2021

The risk of death from any cause was higher with degarelix.

Kidney Cancer

COVID-19 Vaccination Yields High Seroconversion Rates in Renal Cell Carcinoma

Jonathan Goodman, MPhil

November 15, 2021

The seroconversion rate was 92%.

Kidney Cancer

Lenvatinib Plus Pembrolizumab Improves Long-Term Outcomes in Advanced Renal Cell Carcinoma

Jonathan Goodman, MPhil

November 6, 2021

It was previously unknown whether the survival benefits seen with lenvatinib plus pembrolizumab persisted in the long term.

Ethical Issues in Medicine

Experts Disagree on COVID-19 Vaccine Mandates for Health Care Providers

Jonathan Goodman, MPhil

September 30, 2021

Experts outline benefits and detriments of COVID-19 vaccine mandates.

Black men who receive radical prostatectomy experienced longer wait times, higher costs, and poorer

Prostate Cancer

Increased Intensity of PSA Screening May Reduce Racial Disparities in Prostate Cancer

Jonathan Goodman, MPhil

May 26, 2021

Screening intensity was predictive of disease stage and mortality risk.

Urology

COVID-19 Vaccination and Imaging Misinterpretation: An Interview With Lacey McIntosh, DO, MPH

Jonathan Goodman, MPhil

April 6, 2021

Oncologists and patients should be aware of the potential manifestations of the COVID-19 vaccination on imaging and the consequences this might have on disease assessment, treatment monitoring, and decision-making.

Next post in Urology

Jonathan Goodman, MPhil

All articles by Jonathan Goodman, MPhil

Risk of MACE Similar With Degarelix and Leuprolide in Prostate Cancer

COVID-19 Vaccination Yields High Seroconversion Rates in Renal Cell Carcinoma

Lenvatinib Plus Pembrolizumab Improves Long-Term Outcomes in Advanced Renal Cell Carcinoma

Experts Disagree on COVID-19 Vaccine Mandates for Health Care Providers

Increased Intensity of PSA Screening May Reduce Racial Disparities in Prostate Cancer

COVID-19 Vaccination and Imaging Misinterpretation: An Interview With Lacey McIntosh, DO, MPH

Complete TURBT Before Neoadjuvant Chemotherapy Improves MIBC Outcomes